查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1766294

神经内视镜市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

Neuroendoscopy Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024年，全球神经内视镜市场规模达1.688亿美元，预计到2034年将以5.7%的复合年增长率成长，达到2.908亿美元。这一增长主要源于脑肿瘤发生率的上升以及对微创手术的需求不断增长。神经内视镜设备在脑肿瘤（包括胶质瘤和脑下垂体腺瘤）的诊断和治疗中发挥着至关重要的作用。随着全球神经系统疾病发生率的持续上升，对先进专用神经外科器械的需求也随之增长。这些工具在实现更准确的诊断、提高手术精准度和缩短患者復原时间方面发挥关键作用。

神经内视镜市场 - IMG1

随着医疗保健提供者越来越重视能够最大程度减少创伤并改善患者预后的技术，向微创手术的转变正在进一步推动微创手术的普及。导航系统、机器人技术和微型器械的技术进步显着提高了手术能力，使神经外科医生即使在大脑和脊椎等精细复杂的部位也能进行更精准的手术。随着全球医疗保健系统加强对外科基础设施现代化的投资，神经外科器械在应对日益加重的神经系统疾病负担方面发挥更关键的作用。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 1.688亿美元
预测值 2.908亿美元
复合年增长率 5.7%

市场分为硬性神经内视镜和柔性神经内视镜，其中硬性型号收入最高。硬性神经内视镜市场在2024年创造了1.131亿美元的收入，为复杂的手术提供了卓越的功能。这些设备在肿瘤切除和脑室造口术等手术中发挥重要作用，能够清楚观察颅内和脊髓结构。其设计提高了手术的精准度，使其成为神经外科医生的重要工具。

根据可用性，神经内视镜进一步分为可重复使用型和一次性型。可重复使用型神经内视镜市场在2024年创造了1.465亿美元的收入。这些仪器对医疗保健提供者，尤其是在手术量大的机构中，具有经济效益。可重复使用的设备还能支援医疗保健产业的永续发展，因为它们可以减少浪费并符合环境目标。其耐用性和长期成本节约使其在世界各地的医疗机构中越来越受欢迎。

2024年，美国神经内视镜市场规模达5,990万美元，2025年至2034年期间的复合年增长率为4.9%。神经系统疾病发生率的上升以及对高效微创治疗的需求推动了这一增长。美国市场将更多地采用先进技术，例如整合式高清成像系统的机器人神经内视镜。这一转变预计将改善手术效果并缩短患者康復时间，从而推动对神经内视镜手术的需求。

活跃于全球神经内视镜市场的知名公司包括 Machida、ADVANCED BIOLOGICS、B. Braun、CLARUS MEDICAL、Advin Health Care、SCHINDLER ENDOSKOPIE TECHNOLOGIE、KARL STORZ、重庆西山科技、joimax、adeormannCAL 和 Ackercker MEDICAL 和 Ackercker。神经内视镜市场公司采取的关键策略包括投资研发以提高设备精度和小型化，透过先进的成像和导航整合扩展产品组合，以及与医院和学术机构建立策略合作伙伴关係以加速临床应用。领先的参与者还专注于透过加强区域分销网络和获得监管部门的批准来进入尚未开发的市场。持续创新旨在减少手术侵入性和改善患者復原结果，对于保持竞争力和扩大全球影响力仍然至关重要。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

  • 产业生态系统分析
  • 产业衝击力
    • 成长动力
      • 脑瘤病例不断增加
      • 微创外科手术需求激增
      • 神经外科的技术进步
      • 老年人口不断增加
    • 产业陷阱与挑战
      • 设备和手术费用高昂
      • 缺乏熟练的神经外科医生
    • 市场机会
      • 产品创新和客製化
      • 医疗旅游和医疗保健投资不断增长
  • 成长潜力分析
  • 监管格局
    • 我们
    • 欧洲
  • 技术和创新格局
  • 报销场景
  • 差距分析
  • 波特的分析
  • PESTEL分析
  • 未来市场趋势
  • 价值链分析

第四章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 策略仪表板
  • 关键进展
    • 併购
    • 伙伴关係和合作
    • 新产品发布
    • 扩张计划

第五章：市场估计与预测：按产品，2021 - 2034 年

  • 主要趋势
  • 硬质神经内视镜
    • 硬质纤维镜
    • 硬式视讯内视镜
  • 柔性神经内视镜

第六章：市场估计与预测：按应用，2021 - 2034 年

  • 主要趋势
  • 经鼻神经内视镜检查
  • 脑室内神经内视镜检查
  • 经颅神经内视镜检查

第七章：市场估计与预测：按可用性，2021 - 2034 年

  • 主要趋势
  • 可重复使用的神经内视镜
  • 免洗神经内视镜

第 8 章：市场估计与预测：按患者，2021 年至 2034 年

  • 主要趋势
  • 成人
  • 儿科

第九章：市场估计与预测：依最终用途，2021 - 2034 年

  • 主要趋势
  • 医院
  • 门诊手术中心
  • 诊断中心
  • 其他最终用途

第十章：市场估计与预测：按地区，2021 - 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：公司简介

  • Ackermann
  • adeor MEDICAL
  • ADVANCED BIOLOGICS
  • Advin Health care
  • B. Braun
  • Chongqing Xishan Science & Technology
  • CLARUS MEDICAL
  • joimax
  • KARL STORZ
  • Machida
  • SCHINDLER ENDOSKOPIE TECHNOLOGIE
简介目录
Product Code: 4039

The Global Neuroendoscopy Market was valued at USD 168.8 million in 2024 and is estimated to grow at a CAGR of 5.7% to reach USD 290.8 million by 2034. The growth is largely driven by the increasing prevalence of brain tumors and the rising demand for minimally invasive procedures. Neuroendoscopic devices play a crucial role in the diagnosis and treatment of brain tumors, including gliomas and pituitary adenomas. As the global incidence of neurological disorders continues to rise, so does the demand for advanced and specialized neurosurgical instruments. These tools play a critical role in enabling more accurate diagnostics, improved surgical precision, and reduced patient recovery times.

Neuroendoscopy Market - IMG1

The shift toward minimally invasive procedures is further driving adoption, as healthcare providers increasingly prioritize techniques that minimize trauma and enhance patient outcomes. Technological advancements in navigation systems, robotics, and micro-instruments have significantly improved surgical capabilities, allowing neurosurgeons to operate with higher precision even in delicate and complex areas of the brain and spine. As healthcare systems worldwide invest more in modernizing their surgical infrastructure, the role of neurosurgical instruments becomes even more central in addressing the growing burden of neurological diseases.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$168.8 Million
Forecast Value$290.8 Million
CAGR5.7%

The market is divided into rigid and flexible neuroendoscopes, with rigid models generating the highest revenue. The rigid neuroendoscope segment generated USD 113.1 million in 2024, offering superior functionality for complex procedures. These devices are instrumental in procedures like tumor resections and ventriculostomies, offering excellent visibility of intracranial and spinal structures. Their design allows for better precision during surgeries, making them a vital tool for neurosurgeons.

Neuroendoscopes are further categorized based on usability into reusable and disposable types. The reusable neuroendoscopes segment generated USD 146.5 million in 2024. These instruments are economically beneficial for healthcare providers, especially in facilities with a high volume of procedures. Reusable devices also support sustainability efforts in the healthcare sector, as they reduce waste and align with environmental goals. Their durability and long-term cost savings make them increasingly popular in medical facilities worldwide.

United States Neuroendoscopy Market generated USD 59.9 million in 2024 with a CAGR of 4.9% between 2025-2034. This growth is spurred by the increasing incidence of neurological disorders and the need for efficient, minimally invasive treatments. The U.S. market will see enhanced adoption of advanced technologies, such as robotic neuroendoscopes, which integrate high-definition imaging systems. This shift is expected to improve surgical outcomes and patient recovery times, driving demand for neuroendoscopic procedures.

Prominent companies active in the Global Neuroendoscopy Market include Machida, ADVANCED BIOLOGICS, B. Braun, CLARUS MEDICAL, Advin Health Care, SCHINDLER ENDOSKOPIE TECHNOLOGIE, KARL STORZ, Chongqing Xishan Science & Technology, joimax, adeor MEDICAL, and Ackermann. Key strategies adopted by companies in the neuroendoscopy market include investing in research and development to enhance device precision and miniaturization, expanding product portfolios with advanced imaging and navigation integration, and forming strategic partnerships with hospitals and academic institutions to accelerate clinical adoption. Leading players are also focused on entering untapped markets by strengthening regional distribution networks and securing regulatory approvals. Continuous innovation aimed at reducing surgical invasiveness and improving patient recovery outcomes remains central to maintaining competitiveness and expanding global presence.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product trends
    • 2.2.3 Application trends
    • 2.2.4 Usability trends
    • 2.2.5 Patient trends
    • 2.2.6 End use trends
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing number of brain tumor cases
      • 3.2.1.2 Surging demand for minimally invasive surgical procedures
      • 3.2.1.3 Technological advancements in neurosurgery
      • 3.2.1.4 Growing elderly population
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost associated with devices and surgeries
      • 3.2.2.2 Lack of skilled neurosurgeons
    • 3.2.3 Market opportunities
      • 3.2.3.1 Product innovations and customization
      • 3.2.3.2 Rising medical tourism and healthcare investments
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 U.S.
    • 3.4.2 Europe
  • 3.5 Technology and innovation landscape
  • 3.6 Reimbursement scenario
  • 3.7 Gap analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Future market trends
  • 3.11 Value chain analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 By Region
      • 4.3.1.1 North America
      • 4.3.1.2 Europe
      • 4.3.1.3 Asia Pacific
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard
  • 4.7 Key developments
    • 4.7.1 Mergers and acquisitions
    • 4.7.2 Partnerships and collaborations
    • 4.7.3 New product launches
    • 4.7.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Rigid neuroendoscopes
    • 5.2.1 Rigid fiberscopes
    • 5.2.2 Rigid videoscopes
  • 5.3 Flexible neuroendoscopes

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Transnasal neuroendoscopy
  • 6.3 Intraventricular neuroendoscopy
  • 6.4 Transcranial neuroendoscopy

Chapter 7 Market Estimates and Forecast, By Usability, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Reusable neuroendoscopes
  • 7.3 Disposable neuroendoscopes

Chapter 8 Market Estimates and Forecast, By Patient, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Adult
  • 8.3 Pediatric

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 Hospitals
  • 9.3 Ambulatory surgical centers
  • 9.4 Diagnostic centers
  • 9.5 Other end use

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Argentina
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE

Chapter 11 Company Profiles

  • 11.1 Ackermann
  • 11.2 adeor MEDICAL
  • 11.3 ADVANCED BIOLOGICS
  • 11.4 Advin Health care
  • 11.5 B. Braun
  • 11.6 Chongqing Xishan Science & Technology
  • 11.7 CLARUS MEDICAL
  • 11.8 joimax
  • 11.9 KARL STORZ
  • 11.10 Machida
  • 11.11 SCHINDLER ENDOSKOPIE TECHNOLOGIE